Clinical Trials Logo

Sexually Transmitted Diseases clinical trials

View clinical trials related to Sexually Transmitted Diseases.

Filter by:

NCT ID: NCT02612324 Completed - Clinical trials for Sexually Transmitted Infections

An Evaluation of Pono Choices: A Culturally Responsive Teen Pregnancy and STI Prevention Program

Start date: January 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the impact Pono Choices has among youth for teen pregnancy and STI prevention measures such as: initiation of sexual activity; engagement in high risk sexual behaviors; knowledge of pregnancy and STI prevention; attitudes toward healthy sexual behaviors; skills in managing relationships and choices; and intentions about future sexual activity.

NCT ID: NCT02602795 Completed - HIV Clinical Trials

Distress Tolerance and HIV Prevention With XR-NTX Initiation in Opioid Dependence

Start date: December 2015
Phase: N/A
Study type: Interventional

Before starting treatment with XR-NTX, a medication that blocks the positive effects of opioids and helps people stay off opioids, individuals who are dependent on opioids first have to endure a difficult withdrawal process. This study aims to develop and test an intervention to help people who are opioid dependent successfully complete that transition; the investigators will also develop and test a comparison condition aimed at reducing HIV risk behavior.

NCT ID: NCT02593214 Completed - Pregnancy Clinical Trials

Performance and Safety Trial of an Innovative Female Condom (Wondaleaf®)

Start date: August 2015
Phase: N/A
Study type: Interventional

General objective: To assess the performance and safety profile of a novel innovative design of female condom (Wondaleaf®) among healthy married women. Specific objectives : - To determine the failure rate of Wondaleaf®, in terms of clinical breakage, non-clinical breakage, invagination, misdirection, and slippage. - To determine the acceptability and satisfaction of use of Wondaleaf® by subjects and their spouses. - To assess the safety profile of Wondaleaf®.

NCT ID: NCT02579135 Completed - HIV Clinical Trials

Reducing HIV Risk Among Adolescents: Evaluating Project HEART

Start date: September 7, 2015
Phase: N/A
Study type: Interventional

This study evaluates an educational web-based intervention designed to increase adolescent girls' motivation and skills to engage in safer sexual behavior (Project HEART: Health Education and Relationship Training). Half of participants will receive Project HEART and half of participants will receive Project Growing Minds, an attention-matched control website focused on growth mindsets of intelligence and self-regulation. The ultimate goal of this work is to help girls reduce their risk of HIV and other sexually transmitted diseases and to avoid unplanned pregnancies.

NCT ID: NCT02572401 Completed - Clinical trials for Human Immunodeficiency Virus (HIV)

Steering Together in a New Direction: Reducing the Risk of HIV/STD Among African American Men

STAND
Start date: October 2011
Phase: N/A
Study type: Interventional

African American men have by far the highest rates of HIV in the US, but there are few randomized controlled trials (RCTs) of interventions to dissuade heterosexually active African American men from engaging sexual risk behavior. This research seeks to address this gap in the behavioral intervention literature. That self-initiated behavior change, as well as intervention-induced behavior change, is often short-lived, eroding over time, is widely known; accordingly, this research also seeks to test a strategy to sustain intervention efficacy. In a RCT, African American men 18 to 45 years reporting recent unprotected intercourse with a woman will be randomized to the Steering Together in a New Direction (STAND) HIV Risk Reduction Intervention or a No-Intervention Control Condition. To test a strategy to sustain intervention effects, the men also will be randomized to receive or not receive individually tailored text messages. The theoretical basis of the interventions is social cognitive theory and the reasoned action approach, which is an extension of the theory of planned behavior and the theory of reasoned action. Men will complete self-report measures via audio computer-assisted self-interviewing at baseline and immediately post and 6 and 12 months post-intervention. The trial will test whether the STAND HIV Risk Reduction Intervention as compared with the No-Intervention Control Condition, increases consistent condom use, the primary outcome. Secondary outcomes include unprotected intercourse, multiple sexual partners, insertive anal intercourse, and proportion condom-protected intercourse. The trial will also test whether STAND's efficacy is greater among men in the Text Messaging Intervention compared with men not receiving text messages. This will provide information on the utility of a low-cost strategy to extend an intervention's efficacy. Finally, the study will test for mediation of intervention effects: the hypothesis that STAND affects outcome expectancies and self-efficacy, which, in turn, affect consistent condom use.

NCT ID: NCT02561286 Completed - Clinical trials for Sexually Transmitted Disease (STD)

Being Responsible for Ourselves HIV Risk Reduction for Black MSM

BRO
Start date: April 2008
Phase: N/A
Study type: Interventional

The incidence of HIV/AIDS among African American men who have sex with men (MSM) is alarming, and the public health response to this urgent situation has been hampered by a lack of sexual risk reduction interventions with solid evidence of efficacy in this population. Accordingly, the broad, long-term objective of the proposed research is to identify interventions to reduce the risk of sexually transmitted infection (STI) among African American MSM. This application seeks funds to develop and test the efficacy of a theory-based, contextually appropriate behavioral intervention to reduce sexual risk behavior among African American MSM. Intervention development will be guided by social cognitive theory, the theory of planned behavior, qualitative information from focus groups, and findings from a longitudinal survey of men from the study population. A one-on-one intervention will be utilized to address the specific prevention needs of each man and to allay participants' concerns about revealing their sexual involvement with men by virtue of participating in a group or workshop intervention. The study will utilize a randomized controlled trial design, with baseline, immediate post intervention, and 6 and 12 months post intervention assessments. The participants will be African American MSM who will be randomized to a one-on-one sexual risk reduction intervention or a one-on-one health promotion intervention that will serve as the control condition. The primary outcome is consistent condom use during anal and vaginal intercourse. The study will test whether the intervention increases the consistent use of condoms during anal intercourse, the primary outcome, whether it decreases other sexual risk behaviors, and whether social cognitive theory variables mediate the effects of the intervention on consistent condom use. This study will provide an urgently needed intervention to reduce the risk of HIV and other STIs in one of the highest risk populations in the United States.

NCT ID: NCT02552914 Completed - Clinical trials for Sexually Transmitted Diseases, Bacterial

Evaluation of the Use of the Colli-Pee Device to Collect First-void Urine for Molecular Detection of STIs

Colli-Pee
Start date: September 2015
Phase:
Study type: Observational

Study objectives: - To evaluate the usability of the Colli-PeeTM device to collect first-void urine for nucleic acid detection of Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis and Mycoplasma genitalium. - To collect feedback on the easiness of use and the willingness of future use of the Colli-PeeTM device.

NCT ID: NCT02535104 Completed - Clinical trials for Sexually Transmitted Diseases

Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV)

Start date: February 2016
Phase: Phase 1/Phase 2
Study type: Interventional

Ranpirnase in topical formulation is an antiviral drug being evaluated for the topical treatment of anogenital warts. The aims of this study is to evaluate the efficacy and safety of a topical formulation of ranpirnase in subjects with genital warts.

NCT ID: NCT02516930 Completed - Clinical trials for Human Immunodeficiency Virus

A Non-inferiority Randomized Controlled Trial to Evaluate Promoting Condom Use Among MSM and Transgender Individuals in China

Start date: September 2015
Phase: N/A
Study type: Interventional

This is a pragmatic, non-inferiority, randomized controlled trial comparing the effectiveness of two methods (crowdsourcing versus social marketing) for creating one-minute videos promoting condom use among MSM and TG in China. Crowdsourcing is the process of shifting individual tasks to a large group, often involving open contests and enabled through multisectoral partnerships.

NCT ID: NCT02509572 Completed - Clinical trials for Sexually Transmitted Infections

Improvement of STI Detection in Adolescent Emergency Department Patients

SHS
Start date: October 2014
Phase: N/A
Study type: Interventional

The goal of this trial is to test a novel means of collecting patient-entered sexual health information for the provision of clinical decision support to increase the testing and detection of sexually transmitted infections (STI) in adolescent emergency department (ED) patients at high risk for STIs.